跳至主要内容
临床试验/NCT01941498
NCT01941498已完成不适用

A Prospective, Global, Multi-Center Study for the Evaluation of Outcomes on Subjects Undergoing Myopic Treatments Using the WaveLight® Refractive Suite

Alcon Research0 个研究点目标入组 104 人开始时间: 2013年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
104
主要终点
Least Squares Mean Difference in Binocular UCVA at 1 Month Post-Treatment and Pre-Treatment Binocular BCVA

研究概览

简要总结

The purpose of this study is to evaluate outcomes of subjects undergoing myopic surgery using the WaveLight® Refractive Suite (Excimer EX500 and Femtosecond FS200 lasers).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Willing and able to understand and sign an informed consent form.
  • Have refractive error (in both eyes) that requires refractive surgery.
  • Willing to undergo LASIK surgery using the Wavelight® Refractive Suite.
  • Myopia between 0.00 to -12.0 diopters pre-operatively.
  • Astigmatism between 0.00 to +6.00 diopters pre-operatively.
  • Willing and able to attend post-operative examinations per protocol schedule.
  • Other protocol-defined inclusion criteria may apply.

排除标准

  • Participation in a clinical study within the last 30 days.
  • History of previous corneal surgery in either eye.
  • Multifocal ablations in either eye.
  • PRK or PTK surgery in either eye.
  • Suffering from acute or recurring eye diseases in either eye, such as corneal ulcers, cataract, etc.
  • Any ocular disease and/or condition that, in the Investigator's clinical judgment, may put subject at significant risk, compromise study results, or interfere significantly with subject's participation in the study.
  • Unable to discontinue contact lens wear as specified in protocol.
  • History of Herpes simplex or Herpes zoster keratitis.
  • Active ocular rosacea.
  • Lyme disease.
  • History of dry eye that is unresponsive to treatment.
  • Severe ocular allergies.
  • Other medical conditions and use of medications as specified in protocol.
  • Pregnant or planning to become pregnant during the study.
  • Other protocol-specified exclusion criteria may apply.

结局指标

主要结局

Least Squares Mean Difference in Binocular UCVA at 1 Month Post-Treatment and Pre-Treatment Binocular BCVA

时间窗: Month 1

Visual acuity (VA) with corrective devices (BCVA) was assessed binocularly (both eyes together) pre-treatment and subtracted from VA without spectacles or other visual corrective devices (UCVA) assessed binocularly at 1 month post-treatment. VA was measured at a distance of 4 meters and reported in logMAR (logarithm of the minimum angle of resolution), with 0.00 logMAR corresponding to 20/20 Snellen. A negative value indicates an improvement in VA from pre-treatment to Month 1.

次要结局

  • Wavefront Aberrometry(Baseline (Day 0), Month 6 Postoperative)
  • Corneal Curvature as Measured by Keratometry(Baseline (Day 0), Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative)
  • Mean Difference Between Achieved and Target Corneal Flap Thickness as Assessed by OCT(Operation/Surgery (Day 1), Month 1 Postoperative, Month 6 Postoperative)
  • Mean Response: "Rate Your Vision, Over the Past 4 Weeks, With NO Glasses or Contact Lenses"(Baseline (Day 0), Month 1 Postoperative, Month 6 Postoperative)
  • Mean Contrast Sensitivity (CS)(Baseline (Day 0), Day 1 Postoperative, Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative)
  • Percent Response by Category: "In the Past 4 Weeks, to See Far Away, I Wore..."(Baseline (Day 0), Month 1 Postoperative, Month 6 Postoperative)
  • Mean Total Laser Treatment Time(Day 0 (surgery))
  • Percent Response by Category: "I Worry About my Vision"(Baseline (Day 0), Month 1 Postoperative, Month 6 Postoperative)
  • Mean Manifest Refraction (Sphere)(Baseline (Day 0), Operation/Surgery (Day 1), Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative)
  • Mean Manifest Refraction (Cylinder)(Baseline (Day 0), Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative)
  • Mean Laser Treatment Time(Day 0 (surgery))
  • Percent Response by Category: "My Vision Is a Concern in My Daily Life"(Baseline (Day 0), Month 1 Postoperative, Month 6 Postoperative)
  • Percent Response by Category: "Driving at Night"(Baseline (Day 0), Month 1 Postoperative, Month 6 Postoperative)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验